Inside Nvidia’s plan to dominate biotech’s AI revolution

Over the last decade, one tech giant after another has tried to get into healthcare and failed. Amazon’s attempt to reshape costs and delivery sputtered into nothing, IBM’s Watson Health ended in disarray, and Alphabet’s well-funded projects like Verily and Calico have yet to produce anything near the impact of…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks